NAD+ and Aging: What Researchers Know

The NAD+ Decline Problem

NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme that every cell requires to function. It's involved in over 500 enzymatic reactions — from converting food into energy to repairing damaged DNA. Without it, you'd be dead in 30 seconds ^[1].

Here's the problem: NAD+ levels decline dramatically with age. Research shows approximately a 50% reduction between ages 40 and 60. This decline correlates with aging hallmarks — mitochondrial dysfunction, genomic instability, cellular senescence, and metabolic dysregulation.

The central question driving billions of dollars in research: Is the NAD+ decline a cause of aging, or just a consequence?

What NAD+ Actually Does

1. Fuels Sirtuin Enzymes

Sirtuins (SIRT1-SIRT7) are a family of enzymes that require NAD+ as a substrate. They're involved in chromatin remodeling, DNA repair, metabolic regulation, and stress response. When NAD+ drops, sirtuin activity drops with it ^[2].

2. Powers DNA Repair

PARP enzymes (Poly ADP-Ribose Polymerases) consume large amounts of NAD+ to repair DNA damage. As DNA damage accumulates with age, PARPs consume more NAD+, creating a potential vicious cycle.

3. Drives Cellular Energy

NAD+ is essential for Complex I of the mitochondrial electron transport chain — the process that converts food into ATP (cellular energy). Lower NAD+ = lower energy production capacity.

Why NAD+ Drops: The CD38 Connection

Research has identified CD38, an enzyme expressed on immune cells, as one of the primary consumers of NAD+ during aging. CD38 expression increases with chronic low-grade inflammation (inflammaging), and studies show it may be responsible for the majority of age-related NAD+ decline ^[3].

Can We Boost NAD+ Back?

Two main precursors are being studied:

• NMN (Nicotinamide Mononucleotide) — converted to NAD+ via the enzyme NMNAT
• NR (Nicotinamide Riboside) — converted to NMN first, then to NAD+

Human trials with NR (Chromadex's Niagen®) have confirmed it raises blood NAD+ levels. However, the critical question remains unanswered: does raising NAD+ levels produce clinically meaningful health benefits?

Animal data is compelling — NAD+ boosting in mice has shown improvements in endurance, metabolism, and age-related markers. But mice are not humans, and the clinical trial results so far have been modest at best.

What We Honestly Don't Know

• Whether orally boosting NAD+ actually reaches the tissues that need it most
• Whether NAD+ boosting can slow human aging (no trial has demonstrated this)
• The long-term safety profile of chronic NAD+ precursor supplementation
• Whether raising NAD+ in aged cells could have unintended consequences (e.g., fueling cancerous cells) ^[4]

The Bottom Line

NAD+ is unquestionably essential for life, and its decline with age is well-documented. The preclinical data supporting NAD+ repletion is strong. But the human clinical data is still in its early stages, and the leap from "raises a blood biomarker" to "slows aging" has not been made ^[5].

If you see anyone claiming NAD+ supplements "reverse aging" — that claim is not supported by current human evidence. The science is promising, but incomplete.